Response-adapted clinical trial of anthracycline omission

This lecture explores innovative approaches in clinical trials with a focus on response-adapted designs, the role and risks of anthracyclines in oncology, and the rationale for their omission in specific cases. Emphasis will be placed on understanding study methodologies, key findings, and their implications for clinical practice and education. The session aims to enhance the knowledge of healthcare professionals while addressing future developments in treatment strategies. Designed for...